Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 13.30p
  • 52 Week Low: 5.63p
  • Currency: UK Pounds
  • Shares Issued: 443.23m
  • Volume: 11,596
  • Market Cap: £37.67m
  • Beta: 0.01

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

Key Personnel

CEO: Carolyn Cross
CFO and COO: Michael S. Behlke
Chairman: Jean Charest
Chief Technology Officer: Nicolas Loebel
Independent Non-Executive Director: Junaid Bajwa
Independent Non-Executive Director: Simon Sinclair
Interim CFO: Kwong Choo
Senior Independent Non-Executive Director: Jean Duvall
Non-Executive Dir: Craig Tooman

Contact Details

Address: 888 - 1100 Melville Street, Vancouver, British Columbia, Canada, V6E 4A6
Phone: +1 604 669 0555
Website: https://ondinebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: CA68234M2058

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 8.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 13.30p
52 Week Low 5.63p
Volume 11,596
Shares Issued 443.23m
Market Cap £37.67m
Beta 0.01

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.14% below the market average69.14% below the market average69.14% below the market average69.14% below the market average69.14% below the market average
95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average
Price Trend
13.98% above the market average13.98% above the market average13.98% above the market average13.98% above the market average13.98% above the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Income Not Available
Growth
35.05% above the market average35.05% above the market average35.05% above the market average35.05% above the market average35.05% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

OBI Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
08:28 11,596 @ 8.52p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page